Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.42 |
| ▸ | RAB9A | P51151 | 6/20 | 0.42 |
| ▸ | NPC1 | O15118 | 5/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.42 |
| ▸ | RELA | Q04206 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | UHRF1 | Q96T88 | 1/20 | 0.41 |
| ▸ | CCR1 | P32246 | 1/20 | 0.41 |
| ▸ | CCR5 | P51681 | 1/20 | 0.41 |
| ▸ | CCR8 | P51685 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2956488 | 1.00 | SMN1; SMN2 (0.42) | SMN1; SMN2RAB9ANPC1MAPTMEN1 | |
| SCHEMBL12501248 | 0.81 | NPC1 (0.39) | SMN1; SMN2RAB9ANPC1MAPTMEN1 | |
| SCHEMBL24805764 | 0.80 | RAB9A (0.39) | SMN1; SMN2RAB9ANPC1MAPTMEN1 | |
| SCHEMBL457578 | 0.79 | TTR (0.49) | SMN1; SMN2RAB9ANPC1MAPTLMNA | |
| SCHEMBL457579 | 0.79 | TTR (0.49) | SMN1; SMN2RAB9ANPC1MAPTLMNA | |
| SCHEMBL13964557 | 0.79 | ITGB2 (0.42) | SMN1; SMN2RAB9ANPC1MAPTMEN1 | |
| SCHEMBL9756942 | 0.79 | KDM4E (0.50) | SMN1; SMN2RAB9AMAPTMEN1KMT2A | |
| SCHEMBL18989990 | 0.79 | NPSR1 (0.50) | RAB9AMAPTMEN1KMT2AHPGD | |
| SCHEMBL18989993 | 0.79 | NPSR1 (0.50) | RAB9AMAPTMEN1KMT2AHPGD | |
| SCHEMBL9756940 | 0.79 | KDM4E (0.50) | SMN1; SMN2RAB9AMAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3211123-B1 | HORIZONTAL METHOD OF ELECTROLESS METAL PLATING OF SUBSTRATES WITH IONIC CATALYSTS | ROHM & HAAS ELECT MAT (US) | 2019-01-09 | — | — | EP | claimed |
| US-20170251557-A1 | HORIZONTAL METHOD OF ELECTROLESS METAL PLATING OF SUBSTRATES WITH IONIC CATALYSTS | ROHM & HAAS ELECT MAT (US) | 2017-08-31 | — | — | US | claimed |
| EP-3211123-A1 | HORIZONTAL METHOD OF ELECTROLESS METAL PLATING OF SUBSTRATES WITH IONIC CATALYSTS | Rohm and Haas Electronic Materials LLC (US) | 2017-08-30 | — | — | EP | claimed |
| US-8591636-B2 | Plating catalyst and method | ROHM AND HAAS ELECTRONICS MATERIALS LLC (US) | 2013-11-26 | — | — | US | claimed |
| EP-3211123-B1 | HORIZONTAL METHOD OF ELECTROLESS METAL PLATING OF SUBSTRATES WITH IONIC CATALYSTS | ROHM & HAAS ELECT MAT (US) | 2019-01-09 | — | — | EP | disclosed |
| EP-2465974-B1 | Plating catalyst and method | ROHM & HAAS ELECT MAT (US) | 2018-11-28 | — | — | EP | disclosed |
| US-20170251557-A1 | HORIZONTAL METHOD OF ELECTROLESS METAL PLATING OF SUBSTRATES WITH IONIC CATALYSTS | ROHM & HAAS ELECT MAT (US) | 2017-08-31 | — | — | US | disclosed |
| EP-3211123-A1 | HORIZONTAL METHOD OF ELECTROLESS METAL PLATING OF SUBSTRATES WITH IONIC CATALYSTS | Rohm and Haas Electronic Materials LLC (US) | 2017-08-30 | — | — | EP | disclosed |
| US-8961669-B2 | Plating catalyst and method | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2015-02-24 | — | — | US | disclosed |
| US-20140087062-A1 | PLATING CATALYST AND METHOD | ROHM & HAAS ELECT MAT (US) | 2014-03-27 | — | — | US | disclosed |
| US-8591636-B2 | Plating catalyst and method | ROHM AND HAAS ELECTRONICS MATERIALS LLC (US) | 2013-11-26 | — | — | US | disclosed |
| EP-2465974-A2 | Plating catalyst and method | Rohm and Haas Electronic Materials LLC (US) | 2012-06-20 | — | — | EP | disclosed |
| US-20120145554-A1 | PLATING CATALYST AND METHOD | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2012-06-14 | — | — | US | disclosed |
| US-7767665-B2 | 3-[6-(4-oxo-4H-1,3-benzothiazin-2-yl)-2-pyridyl]propionic acid, having an excellent apoptosis inhibitory and Macrophage migration inhibitory factor (MIF) binding effects, used for preventing and/or treating cancers, AIDS, cardiovascular, neurodegeneartive, bone, kidney and liver disoders | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-08-03 | — | — | US | disclosed |
| US-20090082343-A1 | 1,3-BENZOTHIAZINONE DERIVATIVES AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-03-26 | — | — | US | disclosed |
| US-7399759-B2 | 1, 3-benzothiazinone derivatives and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-07-15 | — | — | US | disclosed |
| US-20050032786-A1 | 1, 3-benzothiazinone derivatives and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-02-10 | — | — | US | disclosed |
| EP-1424336-A1 | 1,3-BENZOTHIAZINONE DERIVATIVES AND USE THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2004-06-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090082343-A1 | 1,3-BENZOTHIAZINONE DERIVATIVES AND USE THEREOF | MIF, MORF4L1, FOXM1 | SMN1; SMN2 388/4885RAB9A 4678/4885NPC1 1326/4885 |
| US-20050032786-A1 | 1, 3-benzothiazinone derivatives and use thereof | MIF, MORF4L1, FOXM1 | SMN1; SMN2 388/4885RAB9A 4678/4885NPC1 1326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.